Paige

Transforming Cancer Care with Next-Generation AI

New York, United States · Founded 2017 · $45.0M raised

Headquarters
New York
Employees
51–200
Founded
2017
Business Model
B2B
Website
paige.ai
Total Funding
$45.0M
Last Round
$45.0M Series BDec 2019
Rounds
1

About

Paige is an AI company revolutionizing cancer diagnostics through computational pathology. Spun out of Memorial Sloan Kettering Cancer Center, Paige developed the first FDA-authorized clinical AI application in digital pathology. The platform leverages access to over 25 million digitized pathology slides and genomic data across 40+ cancer types from 800+ institutions in 45+ countries, enabling pathologists to detect and subtype cancers with greater speed and accuracy. Paige's Paige Alba platform supports personalized medicine through deep molecular and cellular analysis. The company was acquired by Tempus to further accelerate AI-driven oncology solutions.

Summary

Paige is an AI company based in New York, United States, founded in 2017. It has raised $45.0M in total across 1 round, most recently a $45.0M Series B round in Dec 2019.

Tech & App Stack

2 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series BSeries BDec 2019
$45.0M

Similar Companies